Palvella Therapeutics Announces First Patients Dosed in Phase 2 TOIVA Clinical Trial of QTORIN™ 3.9% Rapamycin Anhydrous Gel (QTORIN™ rapamycin) for the Treatment of Cutaneous Venous Malformations
Mineralys Therapeutics Announces Phase 2 Clinical Trial of Lorundrostat for Obstructive Sleep Apnea in Patients with Hypertension
DiagnaMed and QIMC to Advance Hydrogen Production Technology at the Ville Marie Clean Natural Renewable Hydrogen Project
Replimune Announces RP2 Development Program Advances with First Patients Enrolled in Metastatic Uveal Melanoma and Hepatocellular Carcinoma Clinical Trials
Coherus Management to Present at the 43rd Annual J.P. Morgan Healthcare Conference
Leading vendor to enable over 21,000 senior care providers on the Carequality Interoperability Framework, marking a significant advancement toward solving...
ST. PAUL, Minn.--(BUSINESS WIRE)--Minnetronix Medical, Inc., a leading medical technology company, today announced that the company’s President, Jeremy Maniak, will...
Kicking Off its Annual User Conference, PointClickCare Welcomes More Than 2,000 Attendees to SUMMIT 2019 DALLAS--(BUSINESS WIRE)--PointClickCare, the leading cloud-based...
Asset Purchase Increases Combined Company Annual Revenue to $44M, Including Previously Announced Acquisition of Innovus Pharmaceuticals Over $5 Million in...
Key Opinion Leader in hepatology and gastroenterology to discuss challenges and opportunities in NAFLD and NASH Company representatives to showcase...
VANCOUVER, BC / ACCESSWIRE / November 4, 2019 / Chemesis International Inc. (CSE:CSI)(OTCQB:CADMF)(FRA:CWAA) (the "Company" or "Chemesis"), announces that it...
SHELTON, CT / ACCESSWIRE / November 4, 2019 / NanoViricides, Inc. (NYSE Amer.:NNVC) (the "Company"), a global leader in nanomedicines...
- First-ever wholly digital population health study that captures data from multiple wearable technologies together with sensitive neuropsychology tests to...
Funds raised will provide diabetes medication for companion animals PORTLAND, Maine--(BUSINESS WIRE)--#Covetrus--In recognition of National Diabetes Month, Covetrus® (NASDAQ: CVET), a global leader...
AUSTIN, Texas--(BUSINESS WIRE)--Apollo Endosurgery, Inc. ("Apollo") (Nasdaq: APEN), a global leader in less invasive medical devices for gastrointestinal and bariatric...
Study found that Hi-VNI Technology during ambulation is feasible Hi-VNI Technology improved recovery time amongst these patients by 32.5% versus...
Significant criteria updates include refocused privacy and security initiatives and new programs devoted to addressing alignment with the Trusted Exchange...
DUBLIN--(BUSINESS WIRE)--The "Additive Manufacturing in Orthopedics: Markets for 3D Printed Medical Implants 2019" report has been added to ResearchAndMarkets.com's offering....
IRVINE, Calif.--(BUSINESS WIRE)--Axonics Modulation Technologies, Inc. (NASDAQ: AXNX), a medical technology company that has developed and is commercializing novel implantable...
Acquisition Adds Security, IT Audit, and Data Privacy Capabilities to its Growing Managed Professional Service Offerings AUSTIN, Texas--(BUSINESS WIRE)--$CTEK #cybersecurity--CynergisTek,...
Nursing Executive Will Develop and Implement Strategies for Customer Adoption, Implementation of LiveData PeriOp Manager CAMBRIDGE, Mass.--(BUSINESS WIRE)--LiveData®, Inc., a...
Company working to raise more awareness of epilepsy through partnerships LONDON--(BUSINESS WIRE)--$LIVN--LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology and innovation...
FORT LAUDERDALE, Fla.--(BUSINESS WIRE)--Motus GI Holdings, Inc., (NASDAQ: MOTS) ("Motus GI" or the "Company"), a medical technology company dedicated to...
Approximately $4.5 Billion in New U.S. Direct Lending Commitments Closed in the Third Quarter and Approximately $11.0 billion in the...
TORONTO, ON / ACCESSWIRE / October 31, 2019 / Theralase® Technologies Inc. ("Theralase" or the "Company") (TSXV:TLT)(OTCQB:TLTFF), a clinical stage...
